Where I see patients (1)
Selected research
-
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma.
Journal for immunotherapy of cancer
-
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
British journal of haematology
-
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Blood cancer journal
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421